Literature DB >> 18052963

IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis.

W-H Piao1, Y H Jee, R L Liu, S W Coons, M Kala, M Collins, D A Young, D I Campagnolo, T L Vollmer, X-F Bai, A La Cava, F-D Shi.   

Abstract

The homeostasis of CD4+ CD25+ regulatory T cells (Tregs) depends on the cytokine interleukin (IL)-2. As IL-21 shares sequence homology with IL-2 and the IL-21 receptors contain a gamma-chain common to IL-2, we hypothesized that IL-21 could also affect the homeostasis of Tregs. We tested this hypothesis in experimental autoimmune encephalomyelitis (EAE), an animal model of relapsing-remitting human multiple sclerosis. We show that blockade of IL-21 in SJL/J mice before and after the induction of EAE enhances the influx of inflammatory cells into the central nervous system (CNS). The blockade of IL-21 leads to proliferation of proteolipid peptide (PLP(139-151))-autoreactive CD4+ T cells, which are capable to cause severe EAE in adoptively transferred recipient mice. Conversely, Tregs from mice where IL-21 was blocked, lose their capacity to prevent EAE induced PLP(139-151)-reactive T cells. Notably, direct effects of IL-21 on Tregs are confirmed by studies of blockade of IL-21 in mice expressing a green fluorescent protein 'knocked' into a Foxp3 allele, in which a reduction of the number of Tregs and a downregulation of their frequency and expression of Foxp3 are observed. These data suggest a role of the IL-21/IL-21R axis in the homeostasis of Tregs in CNS autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18052963     DOI: 10.1111/j.1365-3083.2007.02035.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  19 in total

Review 1.  Development, regulation and functional capacities of Th17 cells.

Authors:  Keiji Hirota; Bruno Martin; Marc Veldhoen
Journal:  Semin Immunopathol       Date:  2010-01-27       Impact factor: 9.623

2.  Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL.

Authors:  Alan M Hanash; Lucy W Kappel; Nury L Yim; Rebecca A Nejat; Gabrielle L Goldberg; Odette M Smith; Uttam K Rao; Lindsay Dykstra; Il-Kang Na; Amanda M Holland; Jarrod A Dudakov; Chen Liu; George F Murphy; Warren J Leonard; Glenn Heller; Marcel R M van den Brink
Journal:  Blood       Date:  2011-05-19       Impact factor: 22.113

Review 3.  Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy.

Authors:  Isabela Pedroza-Pacheco; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

4.  Deletion of Fanca or Fancd2 dysregulates Treg in mice.

Authors:  Wei Du; Ozlem Erden; Andrew Wilson; Jared M Sipple; Jonathan Schick; Parinda Mehta; Kasiani C Myers; Kris A Steinbrecher; Stella M Davies; Qishen Pang
Journal:  Blood       Date:  2014-02-05       Impact factor: 22.113

Review 5.  Th1 and Th17 cells: adversaries and collaborators.

Authors:  Jesse M Damsker; Anna M Hansen; Rachel R Caspi
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

6.  Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis.

Authors:  F Zhou; B Ciric; G-X Zhang; A Rostami
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 7.  The role of cytokines in Guillain-Barré syndrome.

Authors:  Ming-Ou Lu; Jie Zhu
Journal:  J Neurol       Date:  2010-11-23       Impact factor: 4.849

Review 8.  Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity?

Authors:  M I Koenders; W B van den Berg
Journal:  Clin Exp Immunol       Date:  2009-11-11       Impact factor: 4.330

9.  IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).

Authors:  Joanne L Jones; Chia-Ling Phuah; Amanda L Cox; Sara A Thompson; Maria Ban; Jacqueline Shawcross; Amie Walton; Stephen J Sawcer; Alastair Compston; Alasdair J Coles
Journal:  J Clin Invest       Date:  2009-06-22       Impact factor: 14.808

Review 10.  How do regulatory T cells work?

Authors:  A Corthay
Journal:  Scand J Immunol       Date:  2009-10       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.